Atlas Trials

Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients

Clinical trial NCT05155592 · UNKNOWN

Trial details

NCT number
NCT05155592
Sponsor
Dan Liang
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
UveitisAdalimumab
Start date
2021-01-01
Primary completion
2023-01-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.